RE:RE:EU Legislative proposals aims to expedite new medicinesAs concluded, this newly affected collaborated effort by international governments to reduce international "red-tape" and facilitate collective international regulatory decision-making for the approval of new medicines that treat orphan diseases and those with 'unmet treatment needs", now clears the way to advance the expedited approval of new medicines like ONCY's pelareorep in the United States, the UK, and the European Union, either by ONCY or by ONCY's international Big Pharma acquirer.